To confirm these findings, we conducted in silico analysis of a cohort of 855 radically resected primary mammary tumors with clinical annotation for recurrences and observed that breast cancer patients with tumors expressing high ITGA5 mRNA levels were more likely to relapse in bone (HR = 1.36, p = 0.018) (Fig. S2). This evidence concerns the gene ITGA5 and breast cancer.